Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · IEX Real-Time Price · USD

4.690

+0.010 (0.21%)

At close: Jul 19, 2024, 12:00 AM

4.640

-0.050 (-1.07%)

Pre-market: Jul 22, 2024, 9:04 AM EDT

Capricor Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2006
Net Income	-24.31	-22.29	-29.02	-20.02	-13.66	-7.64	Upgrade
Depreciation & Amortization	1.17	1.07	0.53	0.25	0.14	0.17	Upgrade
Share-Based Compensation	8.46	7.39	4.46	2.97	1.95	0.7	Upgrade
Other Operating Activities	-16.39	-11.77	28.94	0	1.51	-0.05	Upgrade
Operating Cash Flow	-31.08	-25.6	4.92	-16.81	-10.05	-6.82	Upgrade
Capital Expenditures	-2.26	-2.05	-3.36	-1.2	-0.55	0	Upgrade
Change in Investments	1.08	7.16	-31.71	0	5.99	-3	Upgrade
Investing Cash Flow	-1.18	5.11	-35.07	-1.2	5.44	-3	Upgrade
Share Issuance / Repurchase	27.87	25.58	4.87	20.23	33.06	9.18	Upgrade
Debt Issued / Paid	0	0	0	0	0.32	0	Upgrade
Financing Cash Flow	27.87	25.58	4.87	20.23	33.38	9.18	Upgrade
Net Cash Flow	-4.39	5.09	-25.28	2.22	28.77	-0.65	Upgrade
Free Cash Flow	-33.33	-27.64	1.56	-18.01	-10.6	-6.82	Upgrade
Free Cash Flow Margin	-123.01%	-109.79%	61.02%	-7352.29%	-3417.38%	-678.74%	Upgrade
Free Cash Flow Per Share	-1.06	-1.03	0.06	-0.78	-0.68	-1.84	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).